1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 2:

Frequency of procedure-related adverse events according to PRU

Quartile (No.)PRUThromboembolic EventsProcedure-Related Aneurysmal PerforationsAll Procedure-Related Adverse Events
1st (47)<2402 (4.3%)1 (2.1%)3 (6.4%)
2nd (46)240–2841 (2.2%)0 (0%)1 (2.2%)
3rd (46)285–3323 (6.5%)0 (0%)3 (6.5%)
4th (47)>3328 (17.0%)2 (4.3%)10 (21.3%)
P valuea.013.605.009
  • a χ2 test for trends.